The proximal J kappa germline-transcript promoter facilitates receptor editing through control of ordered recombination.

by Christian Vettermann, Greg A Timblin, Vivian Lim, Ernest C Lai, Mark S Schlissel
Published 2015-01-01

Monitoring cell-mediated immune responses in AAV gene therapy clinical trials using a validated IFN-γ ELISpot method

by Kathryn S. Patton, M. Travis Harrison, Brian R. Long, Kelly Lau, Jennifer Holcomb, Rachel Owen, Theresa Kasprzyk, Sylvia Janetzki, Stephen J. Zoog, Christian Vettermann
Published 2021-09-01

The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy

by Brian R. Long, Krystal Sandza, Jennifer Holcomb, Lucy Crockett, Gregory M. Hayes, Jeremy Arens, Carlos Fonck, Laurie S. Tsuruda, Becky Schweighardt, Charles A. O’Neill, Stephen Zoog, Christian Vettermann
Published 2019-06-01